You have 9 free searches left this month | for more free features.

immunogenicity

Showing 1 - 25 of 8,992

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)

Recruiting
  • COVID-19
  • +3 more
  • Omicron-containing COVID-19 vaccine
  • influenza vaccine
  • Seoul, Guro-gu, Korea, Republic of
  • +1 more
Oct 17, 2023

Pneumococcal Infections Trial in Adelaide (Gamma-PN3, Pneumovax-23, Prevenar-13)

Recruiting
  • Pneumococcal Infections
  • Gamma-PN3
  • +3 more
  • Adelaide, South Australia, Australia
    University of Adelaide
Aug 1, 2023

COVID-19 Trial in Melbourne (EG-COVII)

Recruiting
  • COVID-19
  • EG-COVII
  • Melbourne, Victoria, Australia
    Nucleus Network Pty Ltd- Melbourne
Oct 24, 2023

Immunosuppression, COVID-19 Trial in Madison (NVX-CoV2372)

Not yet recruiting
  • Immunosuppression
  • COVID-19
  • NVX-CoV2372
  • Madison, Wisconsin
    UW School of Medicine and Public Health
Aug 31, 2023

Zoster, Systemic Lupus Erythematosus, Vaccine Reaction Trial in Seoul (Shingrix, Placebo)

Recruiting
  • Zoster
  • +2 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Aug 17, 2023

Human Papilloma Virus Trial in Boston (Gardasil9)

Recruiting
  • Human Papilloma Virus
  • Boston, Massachusetts
    Boston Medical Center
Oct 1, 2022

Botulism Trial in Richmond (rBV A/B)

Not yet recruiting
  • Botulism
  • rBV A/B
  • Richmond, California
    California Department of Public Health
Oct 31, 2023

Epidemic Meningitis Trial (MCV4)

Not yet recruiting
  • Epidemic Meningitis
  • MCV4
  • (no location specified)
Jul 5, 2023

Respiratory Syncytial Virus (RSV) Trial in Rochester (RSV vaccine)

Not yet recruiting
  • Respiratory Syncytial Virus (RSV)
  • RSV vaccine
  • Rochester, New York
    University of Rochester Medical Center
Oct 11, 2023

COVID-19 Trial in Toyoake (EXG-5003, Placebo)

Completed
  • COVID-19
  • EXG-5003
  • Placebo
  • Toyoake, Aichi, Japan
    Fujita Health University Hospital
Jan 24, 2023

SARS-CoV-2 Trial in Chengdu (SARS-CoV-2 mRNA vaccine (RBMRNA), CoronaVac®)

Active, not recruiting
  • SARS-CoV-2
  • SARS-CoV-2 mRNA vaccine (RBMRNA)
  • CoronaVac®
  • Chengdu, Sichuan, China
    Chengdu Xinhua Hospital affiliated to North Sichuan Medical Coll
Jun 12, 2023

Vaccination; Infection, Vaccine Adverse Reaction Trial (Recombinant zoster vaccination)

Not yet recruiting
  • Vaccination; Infection
  • Vaccine Adverse Reaction
  • Recombinant zoster vaccination
  • (no location specified)
Jun 9, 2023

Immunogenicity of After Primary Immunization and Booster

Active, not recruiting
  • Polio
  • no intervention
  • Pingxiang, Jiangxi, China
    Shangli Center for Disease Control and Prevention
Sep 21, 2023

Polio Trial (polio vaccines: nOPV2, bOPV, IPV)

Not yet recruiting
  • Polio
  • polio vaccines: nOPV2, bOPV, IPV
  • (no location specified)
Nov 2, 2023

Gastroenteritis Trial (HIL-214, Placebo)

Not yet recruiting
  • Gastroenteritis
  • HIL-214
  • Placebo
  • (no location specified)
Apr 26, 2023

Advanced Solid Tumor Trial in Beijing (LK101 injection)

Recruiting
  • Advanced Solid Tumor
  • LK101 injection
  • Beijing, Beijing, China
  • +1 more
Sep 22, 2023

Hiv Trial (LP-98 injection)

Not yet recruiting
  • Hiv
  • LP-98 injection
  • (no location specified)
Jun 27, 2023

Vaccine-Preventable Diseases, Hepatitis B Trial in Seongnam-si (CVI-HBV-002)

Completed
  • Vaccine-Preventable Diseases
  • Hepatitis B
  • CVI-HBV-002
  • Seongnam-si, Gyeonggi-do, Korea, Republic of
    CHA University Bundang Medical Center
Nov 19, 2023

Advanced Solid Tumors Trial in Shanghai (QLS31903)

Recruiting
  • Advanced Solid Tumors
  • Shanghai, Shanghai, China
    Fudan Zhongshan Hospital
Apr 20, 2023

Tetanus Trial in Shangqiu (Investigational tetanus vaccine, adsorbed, Control tetanus vaccine, adsorbed)

Recruiting
  • Tetanus
  • Investigational tetanus vaccine, adsorbed
  • Control tetanus vaccine, adsorbed
  • Shangqiu, Henan, China
    Liangyuan District Center for Disease Control and Prevention
Sep 15, 2023

Hepatitis A Trial (Healive (hepatitis A vacine(human diploid cell), inactivated))

Not yet recruiting
  • Hepatitis A
  • Healive (hepatitis A vacine(human diploid cell), inactivated)
  • (no location specified)
Sep 21, 2023

Two Domestic HPV Vaccines and Imported HPV Vaccines in Women

Not yet recruiting
  • HPV Infection
  • +2 more
  • Follow up
  • Fuzhou, Fujian, China
    Fujian Maternity and Child Health Hospital
Nov 16, 2023

Healthy Volunteers Trial in Shanghai (CMAB007, Xolair)

Completed
  • Healthy Volunteers
  • CMAB007
  • Xolair
  • Shanghai, China
    Shanghai Xuhui Central Hospital
Jun 8, 2023

Diphtheria, Tetanus, Pertussis Trial (DTaP-HepB-IPV-Hib vaccine)

Not yet recruiting
  • Diphtheria
  • +5 more
  • DTaP-HepB-IPV-Hib vaccine
  • (no location specified)
Jul 11, 2023

Safety of a Single Dose of COMVIGEN Vaccine, Reactogenicity of a Single Dose of COMVIGEN Vaccine, Immunogenicity of a Single

Not yet recruiting
  • Safety of a Single Dose of COMVIGEN Vaccine
  • +5 more
  • Comvigen (Bivalent, ChulaCov19 BNA159.2)
  • BIVALENT Pfizer/BNT vaccine
  • Bangkok, Thailand
  • +1 more
Jun 29, 2023